RY 152.64 -0.722% TD 79.42 -0.3638% SHOP 86.76 0.2311% CNR 165.66 -0.2529% ENB 50.17 0.8645% CP 114.78 0.4463% BMO 119.46 0.395% TRI 223.44 -0.1118% CNQ 48.32 -1.2265% BN 63.27 -0.1263% ATD 82.05 -0.231% CSU 4214.73 0.4019% BNS 64.16 -1.1707% CM 68.67 0.0146% SU 52.85 -0.7139% TRP 56.41 2.0441% NGT 64.6 -0.9202% WCN 247.72 -0.394% MFC 35.62 -0.6138% BCE 45.62 -0.2405%

Delta 9 Cannabis Inc

Healthcare CA DN


Last update at 2024-07-19T13:30:00Z

Day Range


52 Week Range



  • Previous Close 0.01
  • Market Cap5.21M
  • Volume0
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-12.24773M
  • Revenue TTM71.15M
  • Revenue Per Share TTM0.43
  • Gross Profit TTM 17.32M
  • Diluted EPS TTM-0.15


Income Statement


Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -27.83695M -11.54324M -5.08418M 13.52M -8.58453M
Minority interest 0.64M -0.03526M 0.93M -0.00543M -0.15252M
Net income -28.11255M -11.14223M -5.48520M 31.15M -8.48557M
Selling general administrative 19.21M 8.49M 9.35M 9.77M 9.60M
Selling and marketing expenses 0.66M 10.58M 6.62M 4.83M 2.08M
Gross profit 10.88M 17.32M 18.00M 16.40M 5.74M
Reconciled depreciation 7.97M 6.48M 5.31M 3.55M 0.96M
Ebit -20.25826M -7.63929M -2.07907M -2.07392M -8.50100M
Ebitda -12.45161M -1.16925M 3.24M 1.47M -7.51512M
Depreciation and amortization 7.81M 6.47M 5.31M 3.55M 0.99M
Non operating income net other - - - - -
Operating income -20.25826M -7.63929M -2.07907M -2.07392M -8.50100M
Other operating expenses 83.49M 69.93M 54.81M 33.97M 16.07M
Interest expense 6.51M 3.90M 3.20M 1.81M 0.11M
Tax provision 0.00000M -0.40102M 0.40M 0.00000M -
Interest income 3.12M 3.35M 0.04M 1.63M 0.12M
Net interest income -6.97936M -4.26879M -3.15421M -1.75503M 0.12M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 0.28M -0.40102M 0.40M -17.62993M -0.09896M
Total revenue 63.23M 62.29M 52.05M 31.77M 7.57M
Total operating expenses 31.14M 24.96M 20.77M 18.60M 14.24M
Cost of revenue 52.35M 44.97M 34.05M 15.36M 1.83M
Total other income expense net -7.57869M -3.90395M -3.00511M 15.59M -0.08353M
Discontinued operations - - - - -
Net income from continuing ops -27.83695M -11.14223M -5.48520M 13.52M -8.58453M
Net income applicable to common shares -27.20056M -11.17749M -6.41753M 13.74M -8.48557M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 89.55M 74.78M 76.40M 66.16M 45.98M
Intangible assets 0.00000M 0.15M 0.15M - -
Earning assets - - - - -
Other current assets 0.38M 0.30M 0.15M 0.18M 0.32M
Total liab 83.01M 49.50M 41.56M 31.73M 10.67M
Total stockholder equity 6.56M 24.67M 35.00M 34.44M 35.46M
Deferred long term liab - - - - -
Other current liab 12.43M 7.99M 8.54M 4.53M 0.39M
Common stock 72.58M 64.08M 53.16M 55.38M 53.16M
Capital stock 72.58M 64.08M 53.16M 55.38M 53.16M
Retained earnings -54.56966M -27.36911M -21.59561M -7.39126M -21.13585M
Other liab - 1.19M 1.17M - -
Good will 14.20M 2.91M 0.66M - -
Other assets - 0.27M 0.51M - 2.76M
Cash 3.52M 0.94M 8.08M 5.85M 16.23M
Cash and equivalents - - - - -
Total current liabilities 52.81M 40.30M 15.77M 11.40M 5.75M
Current deferred revenue 0.60M 0.56M 0.45M 0.22M 0.12M
Net debt 62.62M 35.76M 27.65M 23.03M -10.83567M
Short term debt 37.26M 28.70M 9.20M 8.54M 0.48M
Short long term debt 29.81M 11.34M 0.15M 0.64M 0.53M
Short long term debt total 66.14M 36.71M 35.73M 28.87M 5.39M
Other stockholder equity 7.83M 7.23M 3.44M 5.49M 4.58M
Property plant equipment 47.42M 40.21M 41.60M 37.00M 16.77M
Total current assets 27.20M 30.72M 32.52M 27.97M 26.38M
Long term investments 0.53M 0.53M 0.93M 1.15M 2.76M
Net tangible assets - 21.62M 31.17M 34.39M 35.39M
Short term investments - - - - -
Net receivables 2.57M 5.64M 5.37M 5.56M 2.03M
Long term debt 15.59M 2.48M 22.93M 18.51M 4.92M
Inventory 19.82M 22.59M 17.86M 14.96M 6.35M
Accounts payable 2.53M 3.05M 1.85M 0.37M 4.77M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -19.27415M -19.27415M - -19.04000M -1.13823M
Additional paid in capital - - - - -
Common stock total equity - - - 55.38M 53.16M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.20M 0.27M 0.51M 38.19M 19.60M
Deferred long term asset charges - - - - -
Non current assets total 62.35M 44.06M 43.88M 38.19M 19.60M
Capital lease obligations 20.74M 12.17M 10.69M 8.58M -
Long term debt total 28.88M 8.01M 26.53M 20.33M 4.92M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -13.86514M 0.89M 0.89M -14.06700M -20.52082M
Change to liabilities - 5.80M 4.28M -2.29865M 4.78M
Total cashflows from investing activities -13.86514M -2.86041M -6.31796M -14.06700M -20.52082M
Net borrowings - -4.09567M 2.13M 14.60M 5.39M
Total cash from financing activities 16.80M -3.49830M 7.04M 15.81M 22.03M
Change to operating activities - -0.96493M -0.43693M 0.25M -1.28844M
Net income -27.83695M -11.14223M -5.48520M 13.52M -8.58453M
Change in cash -0.72184M -7.13419M 2.23M -10.38305M -7.31885M
Begin period cash flow 4.24M 8.08M 5.85M 16.23M 23.55M
End period cash flow 3.52M 0.94M 8.08M 5.85M 16.23M
Total cash from operating activities -3.65746M -0.77548M 1.51M -12.13037M -8.82747M
Issuance of capital stock 1.72M 0.00000M 5.01M 1.15M 16.71M
Depreciation 7.97M 6.48M 5.31M 3.55M 0.96M
Other cashflows from investing activities -11.50180M -0.28090M -0.47952M -0.03333M -3.00000M
Dividends paid - - - - -
Change to inventory 1.58M -5.67142M -6.41828M -2.23093M -2.11680M
Change to account receivables 1.80M 0.49M 0.45M -3.70463M -1.71413M
Sale purchase of stock 1.72M 0.00000M 5.01M 1.15M 16.71M
Other cashflows from financing activities 46.49M 1.11M 5.73M 16.78M 5.40M
Change to netincome - 4.68M 4.30M -21.44189M -0.96332M
Capital expenditures 2.36M 2.58M 5.84M 14.03M 17.52M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 7.62M -0.75303M -1.68715M -7.97932M -0.33525M
Stock based compensation 1.62M 1.46M 1.62M 1.44M 2.62M
Other non cash items 6.97M 3.18M 1.75M -22.65583M -3.48659M
Free cash flow -6.02080M -3.35498M -4.33090M -26.16403M -26.34829M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
Delta 9 Cannabis Inc
- -% 0.01 - 30.03 0.07 0.65 0.96 -10.9891
Bausch Health Companies Inc
0.34 3.36% 10.46 - 2.10 0.47 18.74 3.89 18.18
Tilray Inc
-0.03 1.20% 2.47 - 1000.00 2.91 0.45 3.43 -1.9457
Cronos Group Inc
0.05 1.56% 3.26 - - 11.24 0.67 0.07 1.02
TerrAscend Corp.
-0.08 4.35% 1.76 - - - -

Reports Covered

Stock Research & News


Delta 9 Cannabis Inc., together with its subsidiaries, operates as an integrated cannabis company. The company engages in the cultivation, processing, extraction, wholesale distribution, retail, and sale of medical and recreational cannabis products. Its products include dried cannabis flowers, pre-rolls, and dried sift cannabis, as well as oils, and extracted and derivative products. The company also offers grow pods and live plants to other licensed and pre-licensed companies. In addition, it operates as a medical clinic that provides physician consultation services to patients seeking a medical recommendation for a cannabis prescription. The company operates retail stores under the Delta 9 brand name across the Canadian provinces. It also exports its products to Australia. Delta 9 Cannabis Inc. was incorporated in 2001 and is based in Vancouver, Canada.

Delta 9 Cannabis Inc

P.O. Box 68096, Winnipeg, MB, Canada, R3L 2V9

Key Executives

Name Title Year Born
Mr. John William Arbuthnot IV Co-Founder, CEO & Director 1990
Mr. John William Arbuthnot III Co-Founder & Director 1954
Mr. James Lawson CFO, Controller & Sec. 1952
Mr. Mark Jonker Chief Operations Officer NA
Mr. Matthew Sodomsky Chief Technology Officer NA
Mr. Derek Reimer VP of Compliance NA
Mr. Marshall Posner Chief Marketing Officer NA
Dr. David M. Kideckel M.B.A., MBA, Ph.D. Exec. VP and Head of Strategy, Corp. Devel. & Capital Markets 1980
Mr. Ian Chadsey VP of Corp. Affairs NA
Ms. Alexa Goertzen Sr. Exec. Assistant NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.